India Diagnostic Labs Market Research Report: Forecast (2026-2032)

By Test Type (Pathology, Radiology & Imaging), By Pathology Test Type (Clinical Chemistry, Hematology, Immunology & Serology, Microbiology, Histopathology & Cytopathology, Molecular Diagnostics, Genet... ... r Diagnostics, Genetic Testing), By Radiology Type (X-Ray, Ultrasound, CT Scan, MRI, Mammography, PET-CT, Nuclear Imaging, Others), By Service Delivery Mode (Walk-in Testing, Home Sample Collection, Mobile Diagnostic Units), By Disease Type (Infectious Diseases, Oncology, Diabetes & Endocrinology, Cardiology, Neurology, Nephrology, Gastroenterology, Gynecology & Obstetrics, Respiratory Disorders), By End-User (Hospitals, Physician Clinics, Independent Diagnostic Centers, Corporate & Preventive Health Programs, Government & Public Healthcare Institutions), and others Read more

  • Healthcare
  • Aug 2026
  • 140
  • PDF, Excel, PPT

India Diagnostic Labs Market Key Takeaways

  • The India diagnostic labs market reached USD 18.55 billion in 2025 and is projected to reach USD 37.13 billion by 2032, up from USD 20.48 billion in 2026.
  • The industry is projected to expand at a CAGR of 10.42% during the forecast period.
  • The market remains highly fragmented, with the top five organized diagnostic players collectively accounting for approximately 6% of the overall market.
  • Pathology is the leading test-type segment, accounting for approximately 56% of the diagnostics industry.
  • Hospitals represent the largest end-user segment, capturing approximately 37% of the market.

India Diagnostic Labs Market Size and Outlook

The diagnostic labs market in India was valued at USD 18.55 billion in 2025 and is projected to reach USD 20.48 billion in 2026, expanding to USD 37.13 billion by 2032 at a 10.42% CAGR during 2026–2032. Market expansion is supported by India's large and increasingly health-conscious population, rising demand for preventive screening, growing prevalence of chronic and infectious diseases, and expansion of public healthcare diagnostics. Government initiatives such as Ayushman Bharat, the National Programme for Prevention and Control of NCDs, and Ayushman Arogya Mandirs are improving diagnostic accessibility beyond metropolitan centers. Simultaneously, expanding diagnostic chains, home sample collection, digital health infrastructure, molecular testing, genomic diagnostics, and investments in laboratory automation are increasing testing capacity and broadening India's diagnostic services portfolio.

India Diagnostic Labs Market Key Indicators

  • Government sources report that NCDs account for approximately 63% of deaths in India, with cardiovascular diseases contributing 27%, chronic respiratory diseases 11%, cancers 9%, and diabetes 3%. The high NCD burden sustains demand for blood chemistry, diabetes, cardiac, oncology, kidney, liver, and preventive diagnostic testing, supporting recurring laboratory volumes.
  • The ICMR-INDIAB study covered 113,106 individuals across 30 states/UTs and reported an overall diabetes prevalence of 6%, highlighting substantial nationwide diagnostic requirements. Rising diabetes prevalence increases recurring demand for glucose, HbA1c, lipid, kidney-function, and related monitoring tests, directly expanding pathology-testing volumes.
  • India's National NCD Portal records 97 crore enrolled beneficiaries and 8.64 crore patients under treatment for hypertension and diabetes, with the system adopted across 31 States/UTs. Government-led screening and long-term disease management increase diagnostic-test frequency, creating sustained demand for routine pathology, preventive screening, and disease-monitoring services.
  • The Integrated Disease Surveillance Programme has sanctioned 441 District Public Health Laboratories across 36 States/UTs, with 397 laboratories functional as of March 2026.
    Expansion of district-level laboratory capacity improves access to microbiology, serology, and molecular testing, particularly outside major cities, increasing diagnostic utilization across underserved regions.
  • The Ayushman Bharat Digital Mission's Health Facility Registry covers diagnostic laboratories and imaging centres, while ABDM enables patients to access and share digital laboratory reports through ABHA. Digital integration improves report accessibility, interoperability, patient engagement, and laboratory connectivity, supporting organized diagnostic chains and accelerating adoption of digital laboratory-management systems.

India Diagnostic Labs Market Scope

 Category  Segments
By Test Type Pathology, Radiology & Imaging
By Pathology Test Type Clinical Chemistry, Hematology, Immunology & Serology, Microbiology, Histopathology & Cytopathology, Molecular Diagnostics, Genetic Testing
By Radiology Type X-Ray, Ultrasound, CT Scan, MRI, Mammography, PET-CT, Nuclear Imaging, Others
By Service Delivery Mode Walk-in Testing, Home Sample Collection, Mobile Diagnostic Units
By Disease Type Infectious Diseases, Oncology, Diabetes & Endocrinology, Cardiology, Neurology, Nephrology, Gastroenterology, Gynecology & Obstetrics, Respiratory Disorders
By End-User Hospitals, Physician Clinics, Independent Diagnostic Centers, Corporate & Preventive Health Programs, Government & Public Healthcare Institutions

India Diagnostic Labs Market Growth Drivers

Rising Chronic-Disease Burden and Preventive Diagnostic Testing

The rising burden of chronic diseases and the resulting need for preventive and continuous diagnostic testing is one of the strongest demand-side drivers of India's diagnostic labs industry. The Government of India estimates that non-communicable diseases account for 63% of all deaths in India, with cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes representing major contributors. The government's National Programme for Prevention and Control of NCDs therefore emphasizes population-based screening, early diagnosis, treatment, and follow-up for people aged 30 years and above.

The addressable testing population is substantial. The ICMR-INDIAB study covered 113,106 individuals across 30 states/UTs and recorded a diabetes prevalence of 9.6%, demonstrating the large population requiring diagnostic screening and recurring disease monitoring. In parallel, the Ministry of Health's NCD programme has established a nationwide digital screening and management framework, creating a stronger institutional requirement for diagnostic testing.

Commercial demand is also evident. In FY2026, Tata 1mg's diagnostics business surpassed approximately USD 70 million in annualized revenue and grew more than 40% year over year, while its network reached 19 NABL-accredited laboratories serving 70 cities.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. India Diagnostic Labs Market Policies, Regulations, and Product Standards
  5. India Diagnostic Labs Market Trends & Developments
  6. India Diagnostic Labs Market Dynamics
    1. Growth Factors
    2. Challenges
  7. India Diagnostic Labs Market Hotspot & Opportunities
  8. India Diagnostic Labs Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Segmentation & Analysis
      1. By Test Type- Market Size & Forecast 2022-2032, USD Million
        1. Pathology
        2. Radiology & Imaging
      2. By Pathology Test Type- Market Size & Forecast 2022-2032, USD Million
        1. Clinical Chemistry
        2. Hematology
        3. Immunology & Serology
        4. Microbiology
        5. Histopathology & Cytopathology
        6. Molecular Diagnostics
        7. Genetic Testing
      3. By Radiology Type- Market Size & Forecast 2022-2032, USD Million
        1. X-Ray
        2. Ultrasound
        3. CT Scan
        4. MRI
        5. Mammography
        6. PET-CT
        7. Nuclear Imaging
        8. Others
      4. By Service Delivery Mode- Market Size & Forecast 2022-2032, USD Million
        1. Walk-in Testing
        2. Home Sample Collection
        3. Mobile Diagnostic Units
      5. By Disease Type- Market Size & Forecast 2022-2032, USD Million
        1. Infectious Diseases
        2. Oncology
        3. Diabetes & Endocrinology
        4. Cardiology
        5. Neurology
        6. Nephrology
        7. Gastroenterology
        8. Gynecology & Obstetrics
        9. Respiratory Disorders
        10. Orthopedics
        11. Others
      6. By End-User- Market Size & Forecast 2022-2032, USD Million
        1. Hospitals
        2. Physician Clinics
        3. Independent Diagnostic Centers
        4. Corporate & Preventive Health Programs
        5. Government & Public Healthcare Institutions
      7. By Region- Market Size & Forecast 2022-2032, USD Million
        1. North
          1. National Capital Region (Delhi NCR)
          2. Uttar Pradesh
          3. Punjab
          4. Rajasthan
        2. South
          1. Karnataka
          2. Tamil Nadu
          3. Telangana
          4. Kerala
        3. East
          1. West Bengal
          2. Odisha
        4. West
          1. Maharashtra
          2. Gujarat
          3. Madhya Pradesh
      8. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
  9. India Pathology Diagnostic Labs Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Segmentation & Analysis
      1. By Pathology Test Type- Market Size & Forecast 2022-2032, USD Million
      2. By Radiology Type- Market Size & Forecast 2022-2032, USD Million
      3. By Service Delivery Mode- Market Size & Forecast 2022-2032, USD Million
      4. By Disease Type- Market Size & Forecast 2022-2032, USD Million
      5. By End-User- Market Size & Forecast 2022-2032, USD Million
      6. By Region- Market Size & Forecast 2022-2032, USD Million
  10. India Radiology & Imaging Diagnostic Labs Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Segmentation & Analysis
      1. By Pathology Test Type- Market Size & Forecast 2022-2032, USD Million
      2. By Radiology Type- Market Size & Forecast 2022-2032, USD Million
      3. By Service Delivery Mode- Market Size & Forecast 2022-2032, USD Million
      4. By Disease Type- Market Size & Forecast 2022-2032, USD Million
      5. By End-User- Market Size & Forecast 2022-2032, USD Million
      6. By Region- Market Size & Forecast 2022-2032, USD Million
  11. India Diagnostic Labs Market Key Strategic Imperatives for Success & Growth
  12. Competitive Outlook
    1. Company Profiles
      1. Dr. Lal PathLabs
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Metropolis Healthcare
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Agilus Diagnostics
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Thyrocare Technologies
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Apollo Diagnostics
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Vijaya Diagnostic Centre
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Redcliffe Labs
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Pathkind Labs
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Aarthi Scans & Labs
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Max Lab
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Others
  13. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .